Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Biochip is a set of diminished microarrays which are placed on a strong substrate that allows many experiments to be executed at the same time to obtain a high throughput in less time. This device contains millions of sensor elements or biosensors. Biochip has been extensively studied and developed to enable large-scale genomic, proteomic and functional genomic analyses. Moreover, biochip comprises mainly three types such as DNA microarray, protein microarray, and microfluidic chip. With the integration of microarray and microfluidic systems, a micro total analysis system, which is often called a lab-on-a-chip (LOC) system, is produced. Furthermore, advances of nanotechnology have continuously reduced the size of the biochip which in turn reduced the manufacturing cost and increased the high throughput capability. Owing to all these benefits, this technology has great potential to be a key and powerful tool for clinical research, diagnostics, drug development and toxicology studies.
Some of the key factors driving the biochips market are increasing adoption of targeted & personalized medicine across the globe, rising applications of biochips and advancement in technology. However, the growth of the biochips market is hampered due to the High instrumentation costs and unclear regulatory guidelines. Moreover, the factors such as significant growth prospects in developing countries is the major opportunity in the biochips market.
The biochips market is segmented by product type, technology, application and geography.
Based on product type, the biochips market is segmented into DNA chips, protein chips, lab-on-a-chip and others. Furthermore, others segment is classified into cell arrays and tissue arrays. The DNA chips are widely used around the world owing to its extensive applications in fields such as gene expression, drug discovery, genomic studies, cancer treatment and diagnosis. Furthermore, the high demand for analysis and recognition of genomic disorders are the factors propelling business growth.
The technologies discussed in this market are microfluidics and microarray. Owing to the rising demand for POC diagnostic devices such as glucose monitoring and pregnancy test kits, the microfluidics segment is projected to witness the fastest growth in near future.
Various application were studied in this report such as genomics, proteomics, drug discovery & development and in-vitro diagnostics. The development of biochips has progressively influenced the growth of the miniaturization of products and the automation of processes. The application of biochips in drug discovery and development is expected to be high. Moreover, expression monitoring is the most biologically informative application of this technology at present. Microarray technology has important applications in pharmacogenomics such as drug discovery & development, drug safety and molecular diagnostics. DNA chips have facilitate the integration of diagnosis and therapeutics, as well as the introduction of personalised medicines.
Based on geography, the biochips market is segmented into North America, Europe, Asia Pacific and rest of the world. North America dominated the market in 2018. Growth in this region is majorly driven by the rising prevalence of lifestyle diseases & cardiac disorders and increasing geriatric population in the region. Owing to increasing biotechnology and pharmaceutical companies and low infrastructure costs, the Asia-Pacific is the fastest growing region in the biochips market globally.
The key market players that are dominating the biochips market include Abbott Laboratories, Agilent Technologies, Inc., Perkinelmer, Inc., Fluidigm Corporation, Illumina, Inc., GE Healthcare, Bio-Rad Laboratories Inc., Cepheid Inc., Thermo Fisher Scientific, Inc. and Roche Diagnostics. Leading companies have invested massive capital in research & development and mergers & acquisitions activities to develop innovative products in the market.
The biochips market is segmented by product type, technology, application and geography. Based on product type, these market is segmented into DNA chips, protein chips, lab-on-a-chip and others. Furthermore, others segment is classified into cell arrays and tissue arrays. The DNA chips are widely used around the world owing to its extensive applications in fields such as gene expression, drug discovery, genomic studies, cancer treatment and diagnosis. Furthermore, the high demand for analysis and recognition of genomic disorders are the factors propelling business growth.
The technologies discussed in this market are microfluidics and microarray. Owing to the rising demand for POC diagnostic devices such as glucose monitoring and pregnancy test kits, the microfluidics segment is projected to witness the fastest growth in near future.
Various application were studied in this report such as genomics, proteomics, drug discovery & development and in-vitro diagnostics. The development of biochips has progressively influenced the growth of the miniaturization of products and the automation of processes. The application of biochips in drug discovery and development is expected to be high. Moreover, expression monitoring is the most biologically informative application of this technology at present. Microarray technology has important applications in pharmacogenomics such as drug discovery & development, drug safety and molecular diagnostics. DNA chips have facilitate the integration of diagnosis and therapeutics, as well as the introduction of personalised medicines.
Based on geography, the market is segmented into North America, Europe, Asia Pacific and rest of the world. North America dominated the market in 2018. Growth in this region is majorly driven by the rising prevalence of lifestyle diseases & cardiac disorders and increasing geriatric population in the region. Owing to increasing biotechnology and pharmaceutical companies and low infrastructure costs, the Asia-Pacific is the fastest growing region in the biochips market globally.
Why to buy this report:
